Viewing Study NCT06625333


Ignite Creation Date: 2025-12-25 @ 2:52 AM
Ignite Modification Date: 2026-03-02 @ 4:01 PM
Study NCT ID: NCT06625333
Status: RECRUITING
Last Update Posted: 2025-06-13
First Post: 2024-10-02
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Prospective Non-interventional Study to Evaluate Clinical Outcomes of Ribociclib Combined With Endocrine Therapy in Elderly Patients With HR+HER2 - Advanced Breast Cancer in Routine Clinical Practice in Russian Federation
Sponsor: Novartis Pharmaceuticals
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2024-10-11
Start Date Type: ACTUAL
Primary Completion Date: 2027-10-30
Primary Completion Date Type: ESTIMATED
Completion Date: 2027-10-30
Completion Date Type: ESTIMATED
First Submit Date: 2024-10-02
First Submit QC Date: None
Study First Post Date: 2024-10-03
Study First Post Date Type: ACTUAL
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2025-06-10
Last Update Post Date: 2025-06-13
Last Update Post Date Type: ACTUAL